[
    [
        {
            "time": "",
            "original_text": "科創板融券餘額占比大幅上升，戰投獲配股份提前流通值得商榷",
            "features": {
                "keywords": [
                    "科創板",
                    "融券餘額",
                    "占比上升",
                    "戰投",
                    "配股",
                    "提前流通"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "科創板融券餘額占比大幅上升，戰投獲配股份提前流通值得商榷",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "中國證券金融股份有限公司：恢復脈醫療、中國通號轉融券業務",
            "features": {
                "keywords": [
                    "中國證券金融股份有限公司",
                    "恢復",
                    "脈醫療",
                    "中國通號",
                    "轉融券業務"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "醫療",
                    "基建"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中國證券金融股份有限公司：恢復脈醫療、中國通號轉融券業務",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-08-20",
            "original_text": "證金公司：8月20日起恢復科創板兩只證券轉融券業務",
            "features": {
                "keywords": [
                    "證金公司",
                    "科創板",
                    "轉融券業務",
                    "恢復"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "證金公司：8月20日起恢復科創板兩只證券轉融券業務",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]